Bill Hawkins joined EW as Senior Advisor in the New York office in 2017.
Mr. Hawkins brings to EW decades of experience in building dynamic and innovative healthcare companies, and is among the business leaders in the healthcare industry. Mr. Hawkins is a retired Chairman and CEO of Medtronic, a global innovative medical device company with $100 billion market capitalization, and currently serves as a corporate director on multiple public and private boards as well as for profit and non for profit boards.
Mr. Hawkins serves as Chairman of the Board of Directors of EW portfolio company Bioventus. During his tenure as Chairman, he has guided the evolution of Bioventus into a rapidly growing and profitable orthobiologics company. Mr. Hawkins also serves on the Board of Directors of EW portfolio company TissueTech.
Prior to Medtronic, Mr. Hawkins served as President and Chief Executive Officer of medical device company Novoste Corporation, where he led the development of the company’s innovative stents. Previously, he held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corporation and Eli Lilly & Company. He began his medical technology career with Carolina Medical Electronics in 1977.
Mr. Hawkins has actively served on multiple public and private, as well as non-profit boards. He currently serves as Chairman and previously served as President and CEO of Immucor, a leading global provider of transfusion and transplantation diagnostic products, backed by TPG. He is also the past Chairman and Co-Founder of the Medical Device Innovation Consortium (“MDIC”), and past President of the American Institute of Medical and Biological Engineering (“AIMBE”). He serves as a Director of Halyard Health (NYSE: HYH) and 4-Tech, a cardiology startup in Ireland, Trice Medical, Keratin Biosciences, Virtue Labs and Baebies, and recently joined the Board of the Focused Ultrasound Society. He also serves as a Member of the Advisory Boards at Arboretum Ventures, HealthQuest Ventures, Hatteras Ventures, A*STAR SERC Cluster Advisory Board in Singapore, and the Biomedical Research Council of Singapore.
At his alma mater, Mr. Hawkins was elected to the Duke University Board of Trustees in 2011 and currently serves on the Executive Committee as the Vice Chairman of the Board. He is on the Audit and Compliance Committee, and the Advancing Duke Science and Technology Task Force. He is also Chair of the Board of the Duke University Health System.
Mr. Hawkins received his Bachelor’s degree in Electrical and Biomedical Engineering from Duke University in 1976, and an MBA from the Darden School of Business, University of Virginia, in 1982.